https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidem

Jefferies analyst Roger Song upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Hold to Buy and ra

Inovio Pharmaceuticals NASDAQ: INO said the U.S. Food and Drug Administration has completed several

Inovio Pharmaceuticals, Inc. (INO) Q2 2026 Earnings Call Transcript

U.S. Food and Drug Administration (FDA) review of Biologics License Application (BLA) for INO-3107 a

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.07) per share which beat the an

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

PLYMOUTH MEETING, Pa., Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company fo

Piper Sandler analyst Edward Tenthoff reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Overw

Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular

US stocks rise with Nasdaq up 600 points, Dow up 0.69% and S&P 500 up 1.29%. Tech shares up 5%,

Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.

Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares

Inovio stock fell after hours after pricing a $20 million public offering of common stock and warran

INOVIO Announces Pricing of $20.0 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., July 29

PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a b

Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market sessio

INOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company focused on developing and commerc

PLYMOUTH MEETING, Pa., July 29, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a b

NEW YORK, June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is invest

Inovio Pharmaceuticals, Inc. (INO) Presents at Jefferies Global Healthcare Conference 2026 Transcrip

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i

New York, New York--(Newsfile Corp. - June 1, 2026) - Kuehn Law, PLLC, a shareholder litigation law

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Inovio Pharmaceuticals (NASDAQ:INO)

PLYMOUTH MEETING, Pa., May 28, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company fo

Inovio Pharmaceuticals NASDAQ: INO shareholders approved all proposals presented at the company's 20

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines

Results provide important clinical evidence to support ApolloBio's future regulatory submission in C

https://www.cdc.gov/ebola/situation-summary/index.html

Inovio Pharmaceuticals remains a high-risk, event-driven play, with the investment case dominated by

Inovio Pharmaceuticals, Inc. (INO) Q1 2026 Earnings Call Transcript

Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated appro

Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak.

PLYMOUTH MEETING, Pa., May 8, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focu

Inovio prices a $17.5 million share offering, narrows losses, cuts expenses, and advances INO-3107 u

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares are tumbling Thursday after the company announced t

INOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company focused on developing and commerc

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher on Friday morning after the compa

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.26) per share which beat the an

Akeso, Inc. (9926.HK) ("Akeso"), and INOVIO (NASDAQ: INO) today announced that they have ent